SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001021408-02-006983
Filing Date
2002-05-15
Accepted
2002-05-14 21:44:37
Documents
9
Period of Report
2002-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR PERIOD ENDED 03/31/2002 d10q.htm 10-Q 249053
3 SUBLEASE DATED 01/31/2002 dex101.txt EX-10.1 56388
4 RESEARCH AGREEMENT DATED 07/13/2000 dex102.txt EX-10.2 19976
5 AMDT. #1 TO RESEARCH AGREEMENT DATED 01/16/2001 dex103.txt EX-10.3 2531
6 AMDT. #2 TO RESEARCH AGREEMENT DATED 03/28/2001 dex104.txt EX-10.4 2586
7 AMDT. # 3 TO RESEARCH AGREEMENT DATED 03/18/2002 dex105.txt EX-10.5 2677
8 LICENSE AGREEMENT DATED 08/31/1994 dex106.txt EX-10.6 39607
9 AMDT. # 1 TO LICENSE AGREEMENT DATED 06/19/2000 dex107.txt EX-10.7 8673
10 AMDT. #2 TO LICENSE AGREEMENT DATED 02/15/2002 dex108.txt EX-10.8 3000
  Complete submission text file 0001021408-02-006983.txt   387168
Mailing Address 850 MAUDE AVE MOUNTAIN VIEW CA 94043
Business Address 850 MAUDE AVE MOUNTAIN VIEW CA 94043 4154281550
ESSENTIAL THERAPEUTICS INC (Filer) CIK: 0001010915 (see all company filings)

IRS No.: 943186021 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-28006 | Film No.: 02648343
SIC: 2834 Pharmaceutical Preparations